Written question asked by Baroness Walmsley (Liberal Democrat) on Wednesday, 4 February 2026, in the House of Lords. It was due for an answer on Wednesday, 18 February 2026. It was answered by Baroness Merron (Labour) on Wednesday, 11 February 2026 on behalf of the Department of Health and Social Care.

Medical Treatments

Question: To ask His Majesty's Government what steps they are taking to ensure the uptake of guidelines-directed medical therapies in primary care for (1) cardiovascular disease, (2) diabetes, and (3) chronic kidney disease.

Answer

The National Institute for Health and Care Excellence (NICE) published a strategy in March 2025 setting out a collective ambition for improving uptake and adoption of NICE guidance by the health and care system over the next three years. The strategy aims to improve the uptake and adoption of NICE guidance in priority areas which align with the National Health Service 10-Year Health Plan by 10% by March 2029. This includes guidance on cardiovascular disease and diabetes, further details on which can be found on the NICE website.

In 2023, NHS England published a renal services transformation toolkit to support earlier identification of chronic kidney disease and more joined up services. Eight commissioned regional renal clinical networks are implementing this toolkit, in collaboration with providers. The regional networks are designed to improve care for kidney patients by standardizing treatment, reducing health inequalities, and promoting best practices, including for medical therapy use, across hospitals, commissioners, and specialists.

Secondary information

Type: Written question
Reference: HL14305
Session: 2024-26
Subjects: Diabetes Medical treatments Primary care Cardiovascular diseases Kidney diseases
Link: View this Written question on www.parliament.uk

Medical Treatments

Secondary information

Librarians' tools